Direct-to-patient contact methodology in the context of rare diseases and orphan drugs.

WIEDERKEHR S, MICHEL J, FOURNIE X. Direct-to-Patient Contact unit, Mapi, Lyon, FRANCE. Direct-to-patient contact methodology in the context of rare diseases and orphan drugs. Oral presentation at ORPHANET association forum « NTIC et maladies rares » Paris, 23 September 2013.